Technetium

ATP binding cassette subfamily B member 1 ; Homo sapiens







43 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34988655 Association between gene polymorphism and adverse effects in cancer patients receiving docetaxel treatment: a meta-analysis. 2022 Feb 1
2 30989434 A polymorphism within the mismatch repair gene predicts prognosis and adjuvant chemotherapy benefit in gastric cancer. 2019 Nov 1
3 26954010 Does the Clearance of Inhaled (99m)Tc-Sestamibi Correlate with Multidrug Resistance Protein 1 Expression in the Human Lung? 2016 Sep 2
4 26001650 A case of metastatic renal cell carcinoma and bile duct carcinoma treated with a combination of sunitinib and gemcitabine. 2015 May 22 1
5 25499945 The role of common variants of ABCB1 and CYP7A1 genes in serum lipid levels and lipid-lowering efficacy of statin treatment: a meta-analysis. 2014 Nov-Dec 2
6 23073467 Associations of ABCB1 and IL-10 genetic polymorphisms with sirolimus-induced dyslipidemia in renal transplant recipients. 2012 Nov 15 2
7 23745949 Renal and hepatic kinetics of Tc-99m-labelled hexakis-methoxy-isobutyl Isonitrile. 2012 3
8 19409044 P-glycoprotein versus MRP1 on transport kinetics of cationic lipophilic substrates: a comparative study using [99mTc]sestamibi and [99mTc]tetrofosmin. 2009 Apr 2
9 18279466 Pulmonary elimination rate of inhaled 99mTc-sestamibi radioaerosol is delayed in healthy cigarette smokers. 2008 Apr 2
10 17895794 TC-99m MIBI SPECT imaging in patients with lung carcinoma: is it a functional probe of multidrug resistance genes? 2007 Sep-Oct 4
11 17237619 Determination and prediction of P-glycoprotein and multidrug-resistance-related protein expression in breast cancer with double-phase technetium-99m sestamibi scintimammography. Visual and quantitative analyses. 2006 1
12 15637529 Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer. 2005 Jan 2
13 15011866 Tc-99m MIBI liver imaging for hepatocellular carcinoma: correlation with P-glycoprotein-multidrug-resistance gene expression. 2004 Jan-Feb 3
14 12953149 Using technetium-99m tetrofosmin chest imaging to predict taxol-based chemotherapy response in non-small cell lung cancer but not related to lung resistance protein expression. 2003 3
15 12963129 Usefulness of chest single photon emission computed tomography with technetium-99m methoxyisobutylisonitrile to predict taxol based chemotherapy response in advanced non-small cell lung cancer. 2003 Sep 10 2
16 14575377 The value of Tc-99m-tetrofosmin scintigraphy in the assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors. 2003 Sep 1
17 11901540 Comparison of the expression of P-glycoprotein, Ki-67, and P-53 to technetium-99m tetrofosmin mammoscintigraphic findings. 2002 1
18 11970764 Noninvasive detection of multidrug resistance in patients with hematological malignancies: are we there yet? 2002 Mar 2
19 12029556 Dynamic coupling of 99mTc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients. 2002 Jun 2
20 12043903 The role of Tc-99m sestamibi imaging in predicting clinical response to chemotherapy in lung cancer. 2002 Apr 2
21 12126530 [Correlation of the uptake of technetium-99m methoxyisobutyl isonitrile with expression of multidrug resistance genes mdr-1 and MRP in human lung cancer]. 2002 Jun 25 1
22 12173014 Technetium-99m methoxyisobutylisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistance-related protein expression. 2002 Aug 1
23 11245443 P-Glycoprotein and multidrug resistance-related protein expressions in relation to technetium-99m methoxyisobutylisonitrile scintimammography findings. 2001 Feb 15 1
24 11466674 Prediction of chemotherapeutic response by Technetium 99m--MIBI scintigraphy in breast carcinoma patients. 2001 Jul 15 2
25 11585293 The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response. 2001 Sep 1
26 11891611 Technetium-99m tetrofosmin chest imaging related to p-glycoprotein expression for predicting the response with paclitaxel-based chemotherapy for non-small cell lung cancer. 2001 1
27 10836685 Tc-99m MIBI to evaluate children with Ewing's sarcoma. 2000 Jun 1
28 10928058 Technetium-99m tetrofosmin mammoscintigraphy findings related to the expression of P-glycoprotein mediated multidrug resistance. 2000 May-Jun 1
29 10974159 Monitoring interactions at ATP-dependent drug efflux pumps. 2000 Nov 1
30 10079321 Visualization of multidrug resistance in vivo. 1999 Mar 3
31 10199946 Technetium-99m sestamibi imaging in paediatric neuroblastoma and ganglioneuroma and its relation to P-glycoprotein. 1999 Apr 3
32 9443741 Novel technetium (III)-Q complexes for functional imaging of multidrug resistance (MDR1) P-glycoprotein. 1998 Jan 3
33 9553170 Application of SPET using technetium-99m sestamibi in brain tumours and comparison with expression of the MDR-1 gene: is it possible to predict the response to chemotherapy in patients with gliomas by means of 99mTc-sestamibi SPET? 1998 Apr 2
34 9655294 Technetium-99m methoxyisobutylisonitrile chest imaging of small cell lung carcinoma: relation to patient prognosis and chemotherapy response--a preliminary report. 1998 Jul 1 2
35 9669390 Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy. 1998 Jul 1
36 9669392 P-glycoprotein expression by technetium-99m-MIBI scintigraphy in hematologic malignancy. 1998 Jul 1
37 9712381 Functional retention of Tc-99m MIBI in mediastinal lymphomas as a predictor of chemotherapeutic response demonstrated by consecutive thoracic SPECT imaging. 1998 Aug 1
38 9972367 Preoperative evaluation of the chemosensitivity of breast cancer by means of double phase 99mTc-MIBI scintimammography. 1998 Dec 1
39 9021112 In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients. 1997 Feb 2
40 9225779 Clinical validation of the influence of P-glycoprotein on technetium-99m-sestamibi uptake in malignant tumors. 1997 Jul 1
41 9369495 Characterization of phosphine complexes of technetium(III) as transport substrates of the multidrug resistance P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier. 1997 Nov 18 4
42 9815718 Detection of in vivo P-glycoprotein inhibition by PSC 833 using Tc-99m sestamibi. 1997 Apr 2
43 7636856 Novel hexakis(areneisonitrile)technetium(I) complexes as radioligands targeted to the multidrug resistance P-glycoprotein. 1995 Jul 21 1